Mental Health

0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
2 programs
First Face Training ProgramN/A1 trial
TASC Service Linkages - Discharge Area OnlyN/A1 trial
Active Trials
NCT05998005Recruiting1,000Est. Jun 2026
NCT03616990Active Not Recruiting15,195Est. Dec 2025
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Digital individual-level interventionN/A1 trial
Active Trials
NCT05377398CompletedEst. Sep 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsFirst Face Training Program
City TherapeuticsDigital individual-level intervention
Alliance PharmaceuticalsTASC Service Linkages - Discharge Area Only

Clinical Trials (3)

Total enrollment: 16,195 patients across 3 trials

NCT05998005Alliance PharmaceuticalsFirst Face Training Program

First Face Training Evaluation in Tribal Communities

Start: Aug 2023Est. completion: Jun 20261,000 patients
N/ARecruiting
NCT05377398City TherapeuticsDigital individual-level intervention

MIELITEKO Lifestyle Intervention Study

Start: Aug 2022Est. completion: Sep 2023
N/ACompleted
NCT03616990Alliance PharmaceuticalsTASC Service Linkages - Discharge Area Only

Supportive Release Center Study

Start: Nov 2017Est. completion: Dec 202515,195 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 16,195 patients
3 companies competing in this space